Filing exhibits
- 8-K Current report
- 3.1 Second Amended and Restated Certificate of Incorporation of the Company
- 3.2 Amended and Restated Bylaws of the Company
- 3.3 Certificate of Designation of Series a Preferred Stock of the Company
- 10.2 Amendment to Letter Agreement, Dated September 29, 2023, by and Among Anzu, the Sponsor and Anzu's Officers and Directors
- 10.3 Amended and Restated Registration Rights Agreement, Dated September 29, 2023, by and Among Anzu Special Acquisition Corp I, Anzu Spac GP I LLC and Certain Stockholders
- 10.21 Form of Envoy Medical, Inc. Indemnification Agreement
- 10.22 Envoy Medical, Inc. Equity Incentive Plan
- 10.23 Envoy Medical, Inc. Employee Stock Purchase Plan
- 10.24 Amendment No. 2 to Forward Purchase Agreement, Dated As of September 28, 2023
- 21.1 List of Subsidiaries
- 99.1 Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; Unregistered Sales of Equity Securities; Material Modifications to Rights of Security Holders; Changes in Control of Registrant; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Change in Shell Company Status; Financial Statements and Exhibits
- Download Excel data file
- View Excel data file
Table of Contents